Oct 19, 2023 / 08:30PM GMT
George Ng - Processa Pharmaceuticals, Inc. - CEO
(audio in progress) reformed lawyer. I just want to make sure that you know that I will be making -- likely making forward-looking statements and just wanted to point out a forward-looking statement and disclosure page for you.
About Processa Pharmaceuticals, it's not supposed to have this, but in any event, so I'm the new CEO. I just joined about a month and a half ago and these are the reasons why I'm excited about Processa. You have a situation in which there's a de-risk strategy of developing new chemical antidotes, so it's de-risked in that it's based upon chemotherapy, which is known and used throughout oncology, but yet these are not me-too products. These are next-generation chemotherapy drug products that improve upon and deal with the issues of current chemotherapy has, you know, at this moment.
There's a proven management team that's used their regulatory science approach to develop multiple drugs through approval with over 30 regulatory approvals under their belt through multiple companies, and so I'm excited about that. And I
Processa Pharmaceuticals Inc at ThinkEquity Conference Transcript
Oct 20, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers